did such an accomplished Harvard graduate get talked into such a lucrative board seat? RR must have the magic touch!! I can just here the screaming from the torture chamber...please...please I can't take ( it) anymore:)
You are correct...there is a sucker born every minute. All I have to do is look in the mirror. But, the retail investor on the last offering, did not participate as all shares were gobbled up by one entity. XOMA is vulnerable to the downside with delayed news and a weak market. That's just the facts so play your cards/take your chances on this one.
Now???????? Any year now:( JMO
Nuance has caught the attention of market watcher Herb Greeberg...said a) either someone knows something b) nobody knows anything c) Icahn not selling. Meanwhile rise in $Nuan on no news continues"
Add to your point...Varian has consistently stated that XOMA will not go to P3 trial but will use their 100% results from P2 in combination with Servier P3 to go to FDA.
"Drinking early and often as of late". It's been three long years for me so I took myself off the donor registry! I will say this...RR has consistently said earnings have been impacted by the transition to cloud based rev model. The last cc, not so much! Maybe, just maybe, the lid gets removed this Q. Just read AMZN CC. Or all my thoughts are related to my spiked espresso.